deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01437215

Pilot Study of the Endologix Fenestrated Stent Graft System

Prospective, Multicenter, Single Arm Feasibility and Initial Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms

Sponsor: Endologix

Updated 7 times since 2017 Last updated: Feb 15, 2024 Started: Nov 2, 2010 Primary completion: Sep 30, 2011 Completion: Jul 28, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01437215, this NA trial focuses on Juxtarenal Aortic Aneurysm and Pararenal Aortic Aneurysm and remains completed. Sponsored by Endologix, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotUnknown Status~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2024 · 38 months · monthly snapshotCompleted~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2024 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Mar 2024 [monthly]

    Completed NA

  5. Oct 2019 — Jan 2021 [monthly]

    Completed NA

    Status: Unknown StatusCompleted · Phase: PHASE1NA

Show 2 earlier versions
  1. Jun 2018 — Oct 2019 [monthly]

    Unknown Status PHASE1

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1

    First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Endologix
Data source: Endologix

For direct contact, visit the study record on ClinicalTrials.gov .